Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery to Distribute Haplogen's Haploid Cellular Models

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has inked a worldwide distribution deal covering Haplogen's haploid cellular models.

Under the terms of the deal, effective immediately, customers will be able to purchase directly from Horizon, Haplogen's Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. Horizon said the deal is its first covering the distribution of another company's products.

Haploid cellular models provide researchers a biologically relevant system for the "in vitro genetic analyses of molecular, cellular, and development events in various cell lineages," Horizon said, adding that Haplogen's haploid gene trap mutant collection is the largest haploid cell line bank available. It includes 9,400 mutant clones that affect more than 3,700 human genes and an additional 1,600 inducible clones covering 1,100 genes.

For-profit customers will be able to access the cell-line bank through an annual limited use label license, while academic customers will have access through an unlimited term license. Those customers will also receive a discount of more than 90 percent, Horizon said.

"The addition of the Haplogen cell line products to our offering supports our growth strategy and is highly complementary to our current product portfolio, including our X-MAN range of diploid isogenic cell lines," Horizon CEO Darrin Disley said in a statement.

Financial and other terms of the agreement were not disclosed

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.